Korro Bio, Inc.
KRRO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $117,288 | $163,380 | $339,606 |
| - Cash | $25,155 | $33,612 | $64,144 | $55,643 |
| + Debt | $41,523 | $44,632 | $45,185 | $44,765 |
| Enterprise Value | – | $128,308 | $144,421 | $328,728 |
| Revenue | $1,090 | $1,460 | $2,550 | $2,271 |
| % Growth | -25.3% | -42.7% | 12.3% | – |
| Gross Profit | $1,090 | $1,460 | $2,550 | $2,271 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$16,882 | -$25,975 | -$23,795 | -$21,787 |
| % Margin | -1,548.8% | -1,779.1% | -933.1% | -959.4% |
| Net Income | -$18,061 | -$25,770 | -$23,387 | -$21,199 |
| % Margin | -1,657% | -1,765.1% | -917.1% | -933.5% |
| EPS Diluted | -1.92 | -2.74 | -2.49 | -2.26 |
| % Growth | 29.9% | -10% | -10.2% | – |
| Operating Cash Flow | -$17,179 | -$19,228 | -$24,452 | -$7,495 |
| Capital Expenditures | -$175 | -$140 | -$119 | -$1,452 |
| Free Cash Flow | -$17,354 | -$19,368 | -$24,571 | -$8,947 |